NewslettersHematopoiesis NewsEfficacy and Safety of Eltrombopag in Chinese Patients with Refractory or Relapsed Severe Aplastic AnemiaBy Laurisa Dohm - November 10, 20230123The Phase II multicenter trial investigated the efficacy and safety of eltrombopag in 20 adult Chinese patients with refractory or relapsed severe aplastic anemia.[Scientific Reports]Full Article